For births that occur within an NHS trust and/or with private health providers – whether in a hospital setting or at home with the support of a registered midwife – birth notifications are processed ...

The approval for running MARS in the NHS trusts, foundation trusts and ICBs, is delegated to DHSC, by HM Treasury, annually (for each financial year). Each MARS is required to adhere to national model ...

If you are unable to notify within 36 hours (for example, due to an emergency), you must do so as soon as possible. If it is more than 36 hours since the birth, please contact ...

Based on early estimates over 10,000 extra patients received their care during last week’s BMA strike [25 July 2025 – 30 July 2025] compared to the previous industrial action [27 June 2024 – 02 July ...

Organ transplants not only save lives, they transform them. For our vital organs like hearts and lungs the impact of a ...

New NHS figures show general practice has delivered over 7 million more appointments in the past year compared to last year, taking the total to a record 380 million. Hardworking GP teams carried out ...

The six-month review will examine data and evidence from a range of research and clinical settings, including mental health, sexual and reproductive health, HIV, perinatal care, primary care and ...

England has made remarkable progress in addressing viral hepatitis, stemming from an increased national focus with the advent ...

Matt is Director of Clinical Commissioning in the national specialised commissioning team at NHS England and is the senior ...

Changes to Personal Medical Services (PMS) and Alternative Provider Medical Services (APMS) contracts - updated for the mid year GP contract updates, including the Review Body on Doctors’ and Dentists ...

NHS England » Financial implications and actions for integrated care boards (ICBs) following the mid-year updates to the 2025/26 GP contract ...

NHS England » Icatibant for treatment of moderate to severe acute swellings due to bradykinin-mediated angioedema with normal C1 inhibitor ...